Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 3 call positions ($21.9m notional), 2 put positions ($52.5m notional) – listed below, not included above.
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| GLAXOSMITHKLINE PLC SPONSORED ADR | $48.6m9.88% | — |
| ENSIGN GROUP INC ENSG | $30.7m6.24% | — |
| DANAHER CORPORATION DHR | $30.3m6.16% | — |
| ASCENDIS PHARMA A/S SPONSORED ADR | $28.2m5.74% | — |
| ZOGENIX INC ZGNX | $25.8m5.25% | — |
| SANOFI SNY | $22.2m4.51% | — |
| CHEMOCENTRYX INC CCXI | $20.3m4.13% | — |
| AMARIN CORP PLC SPONS ADR NEW | $19.6m3.99% | — |
| AUDENTES THERAPEUTICS INC BOLD | $18.3m3.72% | — |
| BIOCRYST PHARMACEUTICALS INC BCRX | $16.9m3.44% | — |
| VERTEX PHARMACEUTICALS INC VRTX | $16.0m3.25% | — |
| ENVISTA HOLDINGS CORPORATION NVST | $15.0m3.05% | — |
| PENNANT GROUP INC PNTG | $12.3m2.50% | — |
| MEDICINES CO MDCO | $9.7m1.97% | — |
| SAREPTA THERAPEUTICS INC SRPT | $9.7m1.97% | — |
| APELLIS PHARMACEUTICALS INC APLS | $9.5m1.93% | — |
| TG THERAPEUTICS INC TGTX | $8.6m1.75% | — |
| DECIPHERA PHARMACEUTICALS IN DCPH | $8.0m1.63% | — |
| MODEL N INC MODN | $7.3m1.48% | — |
| FATE THERAPEUTICS INC FATE | $7.1m1.43% | — |
| ASTRAZENECA PLC SPONSORED ADR | $7.0m1.42% | — |
| BLUEBIRD BIO INC COM | $6.4m1.31% | — |
| RADIUS HEALTH INC RDUS | $6.4m1.31% | — |
| ARGENX SE ARGX | $6.0m1.21% | — |
| ILLUMINA INC ILMN | $5.9m1.20% | — |
| OXFORD IMMUNOTEC GLOBAL PLC OXFD | $5.8m1.18% | — |
| R1 RCM INC RCM | $5.4m1.10% | — |
| NATERA INC NTRA | $5.3m1.08% | — |
| KADMON HLDGS INC KDMN | $5.2m1.05% | — |
| GUARDANT HEALTH INC GH | $5.1m1.03% | — |
| QIAGEN NV SHS NEW | $4.6m0.94% | — |
| EHEALTH INC EHTH | $3.0m0.62% | — |
| OMEGA HEALTHCARE INVS INC OHI | $3.0m0.62% | — |
| ELEVANCE HEALTH INC ELV | $3.0m0.61% | — |
| AGILE THERAPEUTICS INC AGRX | $2.8m0.58% | — |
| XENON PHARMACEUTICALS INC XENE | $2.8m0.57% | — |
| LTC PPTYS INC LTC | $2.7m0.54% | — |
| DEXCOM INC DXCM | $2.6m0.54% | — |
| CENTENE CORP DEL CNC | $2.5m0.51% | — |
| IGM BIOSCIENCES INC IGMS | $2.5m0.50% | — |
| AFFIMED N V COM | $2.4m0.48% | — |
| COLLEGIUM PHARMACEUTICAL INC COLL | $2.3m0.47% | — |
| CARETRUST REIT INC CTRE | $2.2m0.46% | — |
| BIODELIVERY SCIENCES INTL IN BDSI | $2.1m0.43% | — |
| OTONOMY INC OTIC | $2.1m0.43% | — |
| AQUESTIVE THERAPEUTICS INC AQST | $2.0m0.41% | — |
| HESKA CORP HSKA | $2.0m0.41% | — |
| ALBIREO PHARMA INC BIOD | $2.0m0.40% | — |
| CYTOKINETICS INC CYTK | $1.9m0.39% | — |
| TELIGENT INC NEW COM | $1.9m0.39% | — |
| HUMANA INC HUM | $1.8m0.37% | — |
| SCPHARMACEUTICALS INC SCPH | $1.7m0.35% | — |
| COMMUNITY HEALTH SYS INC NEW CYH | $1.7m0.34% | — |
| SABRA HEALTH CARE REIT INC SBRA | $1.6m0.33% | — |
| MYOKARDIA INC MYOK | $1.6m0.32% | — |
| SESEN BIO INC COM | $1.4m0.27% | — |
| INFLARX NV IFRX | $1.3m0.27% | — |
| MACROGENICS INC MGNX | $1.3m0.26% | — |
| IMMUNOVANT INC IMVT | $1.2m0.25% | — |
| LIQUIDIA CORPORATION LQDA | $1.2m0.25% | — |
| EIGER BIOPHARMACEUTICALS INC CLDN | $1.0m0.21% | — |
| OPTINOSE INC COM | $968.2k0.20% | — |
| PFENEX INC PFNX | $508.3k0.10% | — |
| FORTY SEVEN INC FTSV | $464.4k0.09% | — |
| TARO PHARMACEUTICAL INDS LTD TARO | $435.5k0.09% | — |
| DICERNA PHARMACEUTICALS INC DRNA | $411.4k0.08% | — |
| AKORN INC AKRX | $60.4k0.01% | — |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $51.5m160.0k shares | — |
| AMARIN CORP PLC Call | $21.3m994.2k shares | — |
| SPECTRUM PHARMACEUTICALS INC SPPI · Put | $1.0m275.6k shares | — |
| TG THERAPEUTICS INC TGTX · Call | $460.6k41.5k shares | — |
| RADIUS HEALTH INC RDUS · Call | $112.9k5.6k shares | — |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |